ClinicalThought

Share

Program Content

Activities

  • New Data in Myeloma Care
    How New Data May Change Myeloma Care in 2018 and Beyond
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 29, 2018

    Expires: January 28, 2019

  • Daratumumab in MM
    How I Improve Patient Outcomes With Daratumumab Therapy
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 02, 2018

    Expires: March 01, 2019

  • Treating SMM
    Smoldering Multiple Myeloma: When to Treat?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 18, 2018

    Expires: April 17, 2019

  • OPTIMISMM: Pomalidomide
    Pomalidomide in Early Relapse Myeloma: Cause for OPTIMISMM
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2018

    Expires: July 24, 2019

  • Selecting PIs in MM
    Selecting the Right Proteasome Inhibitor for Your Patients With Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 24, 2018

    Expires: August 23, 2019

  • New Approaches in R/R MM
    My Thoughts on New Approaches to Manage Relapsed/Refractory Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 29, 2018

    Expires: October 28, 2019

Faculty

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Celgene

Takeda Oncology